NAD

NAD Recommends Pursuit of Research Discontinue All Challenged Claims for Supplement Marketed as ‘Cures’ for Brain Injury, ADHD, Autism

NAD has recommended that Pursuit of Research, LLC, discontinue all challenged claims for the company’s Nutriiveda dietary supplements, which are marketed as “cures” for conditions that include attention deficit disorder, apraxia, autism, diabetes, dyspraxia, seizures, traumatic brain injury and stroke. The advertiser said it will appeal NAD’s decision to NARB.

Read More

NAD Finds Westport Can Support Claims for ZEPHREX-D Following Challenge by Acura Pharmaceuticals

NAD has determined that Westport Pharmaceuticals, LLC, maker of ZEPHREX-D nasal decongestant tablets, can support the claims challenged before NAD by Acura Pharmaceuticals, Inc., the maker of NEXAFED, a competing product.

Read More

NAD Determines Aggregated Online Reviews Don’t Support Claims that Euro-Pro’s Shark Vacuums Are ‘America’s Most Recommended,’ Euro-Pro to Appeal

NAD, in a case of first impression, determined that survey information culled from multiple online venues was insufficiently reliable and representative to support a broad “America’s Most Recommended” claim.

Read More

NAD Recommends iSatori Discontinue Certain Claims for ‘Energize’ Supplement, Finds Company Can Support Certain Claims

NAD has recommended that iSatori, Inc., discontinue certain claims for the company’s Energize dietary supplement, including claims of “8-Hour Efficacy Shown in Clinical Testing.” NAD determined, however, that the advertiser could support certain claims.

Read More

Bell Commits to Discontinue Certain Claims for ‘Virux’ Product; NAD Finds Advertiser Can Support Certain Claims

Bell Lifestyle Products has discontinued certain advertising claims for the company’s “Virux Viral Infections #42,” dietary supplement, action that NAD had determined was necessary. NAD further determined that the company provided adequate substantiation for certain immune-support claims.

Read More

NAD Recommends Hyperion Management Discontinue All Challenged Claims ‘Garcinia Cambogia Formula,’ Better Qualify Guarantee for ‘SaferColon’

NAD has recommended Hyperion Management, LLC, which markets the dietary supplements “Garcinia Cambogia Formula” and “SaferColon,” discontinue all challenged claims for the cambogia product and better disclose limitations the guarantee offered with “SaferColon.”

Read More